Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1993;22:682-687

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gohlke, P.
Right arrow Articles by Unger, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gohlke, P.
Right arrow Articles by Unger, T.

Hypertension, Vol 22, 682-687, Copyright © 1993 by American Heart Association


ARTICLES

Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate

P Gohlke, V Lamberty, I Kuwer, S Bartenbach, A Schnell, W Linz, BA Scholkens, G Wiemer and T Unger
Department of Pharmacology, University of Heidelberg, Frankfurt, Germany.

We investigated functional changes in aortic preparations of spontaneously hypertensive rats treated in utero and subsequently up to 20 weeks of age with the angiotensin converting enzyme (ACE) inhibitors ramipril (0.01 and 1 mg/kg per day) and perindopril (0.01 mg/kg per day). Early-onset treatment with the high dose of ramipril inhibited aortic ACE activity, prevented the development of hypertension, increased aortic vasodilator responses to acetylcholine (10(-8) to 10(- 6) mol/L), decreased vasoconstrictor responses to norepinephrine (10(- 8) mol/L), and increased aortic cyclic GMP content by 160%. Low-dose ramipril inhibited aortic ACE activity and attenuated the aortic vasoconstrictor response to norepinephrine but had no effect on blood pressure. Low-dose treatment with ramipril and perindopril resulted in a significant increase in aortic cyclic GMP content by 98% and 77%, respectively. Long-term coadministration of the bradykinin B2-receptor antagonist Hoe 140 abolished the ACE inhibitor-induced increase in aortic cyclic GMP. Our data demonstrate that long-term treatment with ACE inhibitors can alter vascular function of compliance vessels independently of the antihypertensive action. The increase in aortic cyclic GMP was due to bradykinin potentiating the action of the ACE inhibitors.


This article has been cited by other articles:


Home page
Diabetes CareHome page
A. I. Vinik, T. Erbas, T. S. Park, K. B. Stansberry, J. A. Scanelli, and G. L. Pittenger
Dermal Neurovascular Dysfunction in Type 2 Diabetes
Diabetes Care, August 1, 2001; 24(8): 1468 - 1475.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Makino, M. Sugano, S. Ohtsuka, S. Sawada, and T. Hata
Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats
Cardiovasc Res, December 1, 1999; 44(3): 543 - 548.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Zicha and J. Kunes
Ontogenetic Aspects of Hypertension Development: Analysis in the Rat
Physiol Rev, October 1, 1999; 79(4): 1227 - 1282.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. Linz, P. Wohlfart, B. A. Schoelkens, R. H. A. Becker, T. Malinski, and G. Wiemer
Late Treatment With Ramipril Increases Survival in Old Spontaneously Hypertensive Rats
Hypertension, August 1, 1999; 34(2): 291 - 295.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J.-E. Fabre, A. Rivard, M. Magner, M. Silver, and J. M. Isner
Tissue Inhibition of Angiotensin-Converting Enzyme Activity Stimulates Angiogenesis In Vivo
Circulation, June 15, 1999; 99(23): 3043 - 3049.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Partovian, A. Benetos, J.-P. Pommies, W. Mischler, and M. E. Safar
Effects of a chronic high-salt diet on large artery structure: role of endogenous bradykinin
Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1423 - H1428.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Gohlke, C. Pees, and T. Unger
AT2 Receptor Stimulation Increases Aortic Cyclic GMP in SHRSP by a Kinin-Dependent Mechanism
Hypertension, January 1, 1998; 31(1): 349 - 355.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Linz, T. Jessen, R. H. A. Becker, B. A. Scholkens, and G. Wiemer
Long-term ACE Inhibition Doubles Lifespan of Hypertensive Rats
Circulation, November 4, 1997; 96(9): 3164 - 3172.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Benetos, B. I. Levy, P. Lacolley, F. Taillard, M. Duriez, and M. E. Safar
Role of Angiotensin II and Bradykinin on Aortic Collagen Following Converting Enzyme Inhibition in Spontaneously Hypertensive Rats
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3196 - 3201.
[Abstract] [Full Text]


Home page
HypertensionHome page
G. Wiemer, W. Linz, S. Hatrik, B. A. Scholkens, and T. Malinski
Angiotensin-Converting Enzyme Inhibition Alters Nitric Oxide and Superoxide Release in Normotensive and Hypertensive Rats
Hypertension, November 1, 1997; 30(5): 1183 - 1190.
[Abstract] [Full Text]


Home page
HypertensionHome page
N. Makino, M. Sugano, S. Otsuka, and T. Hata
Molecular Mechanism of Angiotensin II Type I and Type II Receptors in Cardiac Hypertrophy of Spontaneously Hypertensive Rats
Hypertension, October 1, 1997; 30(4): 796 - 802.
[Abstract] [Full Text]


Home page
HypertensionHome page
P. Gohlke, I. Kuwer, A. Schnell, K. Amann, G. Mall, and T. Unger
Blockade of Bradykinin B2 Receptors Prevents the Increase in Capillary Density Induced by Chronic Angiotensin-Converting Enzyme Inhibitor Treatment in Stroke-Prone Spontaneously Hypertensive Rats
Hypertension, January 1, 1997; 29(1): 478 - 482.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Hutri-Kahonen, M. Kahonen, J.-P. Tolvanen, W. Xiumin, K. Sallinen, and I. Porsti
Ramipril therapy improves arterial dilation in experimental hypertension
Cardiovasc Res, January 1, 1997; 33(1): 188 - 195.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Gohlke, W. Linz, B. A. Scholkens, G. Wiemer, and T. Unger
Cardiac and Vascular Effects of Long-term Losartan Treatment in Stroke-Prone Spontaneously Hypertensive Rats
Hypertension, September 1, 1996; 28(3): 397 - 402.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. Mimran, J. Ribstein, and G. DuCailar
Contrasting Effect of Antihypertensive Treatment on the Renal Response to L-Arginine
Hypertension, December 1, 1995; 26(6): 937 - 941.
[Abstract] [Full Text]


Home page
HypertensionHome page
R. D. Paula, C. V. Lima, M. C. Khosla, and R. A.S. Santos
Angiotensin-(1-7) Potentiates the Hypotensive Effect of Bradykinin in Conscious Rats
Hypertension, December 1, 1995; 26(6): 1154 - 1159.
[Abstract] [Full Text]


Home page
HypertensionHome page
G. Berkenboom, D. Brekine, P. Unger, K. Grosfils, M. Staroukine, and J. Fontaine
Chronic Angiotensin-Converting Enzyme Inhibition and Endothelial Function of Rat Aorta
Hypertension, November 1, 1995; 26(5): 738 - 743.
[Abstract] [Full Text]


Home page
HypertensionHome page
D. Rizzoni, M. Castellano, E. Porteri, G. Bettoni, M. L. Muiesan, A. Cinelli, and E. A. Rosei
Effects of Low and High Doses of Fosinopril on the Structure and Function of Resistance Arteries
Hypertension, July 1, 1995; 26(1): 118 - 123.
[Abstract] [Full Text]